R García-Ramos1, E López Valdés2, L Ballesteros3, S Jesús4, P Mir4. 1. Unidad de Trastornos del Movimiento, Servicio de Neurología, Hospital Clínico San Carlos, Universidad Complutense, Madrid, España. Electronic address: garciaramosg@yahoo.es. 2. Unidad de Trastornos del Movimiento, Servicio de Neurología, Hospital Clínico San Carlos, Universidad Complutense, Madrid, España. 3. Servicio de Neurología, Hospital Universitario Infanta Cristina, Parla, Madrid, España. 4. Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, España; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), España.
Abstract
INTRODUCTION: Understanding the social and economic impact of Parkinson's disease is essential for resource planning and raising social awareness. DEVELOPMENT: Researchers reviewed the data published to date on epidemiology, morbidity and mortality, dependency, and economic impact of Parkinson's disease in Spain. In addition, a study has been carried out in order to define the public and private health care resources of Spanish patients affected by Parkinson's disease by means of an e-mail survey of all neurologists specialising in this disease and belonging to the Spanish Society of Neurology's study group for movement disorders. CONCLUSIONS: The incidence and prevalence rates of Parkinson's disease in Spain are similar to those in the rest of Europe. According to current population estimates, there are at least 300.000 patients with Parkinson's disease and one new case per 10.000 habitants per year in Spain. This has a major impact on the patient's quality of life and nearly doubles patient mortality. In addition, the disease generates sizeable costs for the country that may exceed 17.000€ per year per patient; costs will rise due to the ageing of the population and the new therapies employed. Healthcare professionals and administrators dedicate their efforts to providing quality care to patients. Despite the above, we still have a long way to go in order to provide quality, efficient, multidisciplinary, and universal healthcare.
INTRODUCTION: Understanding the social and economic impact of Parkinson's disease is essential for resource planning and raising social awareness. DEVELOPMENT: Researchers reviewed the data published to date on epidemiology, morbidity and mortality, dependency, and economic impact of Parkinson's disease in Spain. In addition, a study has been carried out in order to define the public and private health care resources of Spanish patients affected by Parkinson's disease by means of an e-mail survey of all neurologists specialising in this disease and belonging to the Spanish Society of Neurology's study group for movement disorders. CONCLUSIONS: The incidence and prevalence rates of Parkinson's disease in Spain are similar to those in the rest of Europe. According to current population estimates, there are at least 300.000 patients with Parkinson's disease and one new case per 10.000 habitants per year in Spain. This has a major impact on the patient's quality of life and nearly doubles patientmortality. In addition, the disease generates sizeable costs for the country that may exceed 17.000€ per year per patient; costs will rise due to the ageing of the population and the new therapies employed. Healthcare professionals and administrators dedicate their efforts to providing quality care to patients. Despite the above, we still have a long way to go in order to provide quality, efficient, multidisciplinary, and universal healthcare.
Authors: Rosario Ferrer-Cascales; María José Cabañero-Martínez; Miriam Sánchez-SanSegundo; Nereida Congost-Maestre; Crispin Jenkinson Journal: Health Qual Life Outcomes Date: 2016-11-04 Impact factor: 3.186
Authors: Pablo Martinez-Martín; Carmen Rodriguez-Blazquez; Silvia Paz; Maria João Forjaz; Belén Frades-Payo; Esther Cubo; Jesús de Pedro-Cuesta; Luis Lizán Journal: PLoS One Date: 2015-12-23 Impact factor: 3.240
Authors: Edwin Daniel Oña; Carlos Balaguer; Roberto Cano-de la Cuerda; Susana Collado-Vázquez; Alberto Jardón Journal: Comput Intell Neurosci Date: 2018-04-11
Authors: Esther Cubo; Alvaro Garcia-Bustillo; Alvar Arnaiz-Gonzalez; Jose Miguel Ramirez-Sanz; Jose Luis Garrido-Labrador; Florita Valiñas; Marta Allende; Jeronimo Javier Gonzalez-Bernal; Josefa Gonzalez-Santos; José Francisco Diez-Pastor; Maha Jahouh; Jana Arribas; Jose Trejo Journal: PLoS One Date: 2021-12-21 Impact factor: 3.240
Authors: Ana María Jiménez-Cebrián; Ricardo Becerro-de-Bengoa-Vallejo; Marta Elena Losa-Iglesias; Daniel López-López; César Calvo-Lobo; Patricia Palomo-López; Carlos Romero-Morales; Emmanuel Navarro-Flores Journal: Int J Environ Res Public Health Date: 2021-03-01 Impact factor: 3.390
Authors: Eduardo Candel-Parra; María Pilar Córcoles-Jiménez; Victoria Delicado-Useros; Marta Carolina Ruiz-Grao; Antonio Hernández-Martínez; Milagros Molina-Alarcón Journal: Int J Environ Res Public Health Date: 2022-01-07 Impact factor: 3.390